- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | WHO recommends second malaria vaccine for children | ||
| Di | Sanofi enters agreement with Janssen to develop E. coli vaccine candidate | ||
| Di | NFID and CDC urge US adults to get vaccinated against flu and COVID-19 | ||
| Di | Man vs microbe: the fight against antimicrobial resistance | ||
| Di | Dollo's law | ||
| Mo | Nobel Prize in Medicine awarded to pair of scientists behind mRNA COVID-19 vaccines | ||
| Mo | Biogen's Actemra biosimilar approved by FDA to treat adult and paediatric arthritis | ||
| Mo | Regeneron's odronextamab granted FDA priority review for non-Hodgkin lymphoma | ||
| Mo | The impact of prostate cancer on global health | ||
| Mo | Improvement in rare disease diagnosis and care | ||
| Fr | Further data for AstraZeneca/Daichii Sankyo's Enhertu for breast cancer requested by NICE | ||
| Fr | Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate | ||
| Fr | EDX Medical Group develops multi-disease rapid tests | ||
| Fr | ScreenPoint Medical to showcase AI software at European scientific meeting | ||
| Do | NIHR launches new framework to highlight health progress outcomes | ||
| Do | Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases | ||
| Do | UKHSA secures UK-based vaccine deal for future influenza pandemics | ||
| 27.09. | Novo Nordisk and Valo Health collaborate in deal worth up to $3.3bn | ||
| 27.09. | A landscape review reveals £1.1bn of UK funding for rare diseases | ||
| 27.09. | Cancer Research UK partners with French cancer institute | ||
| 27.09. | Diagnosis pathway launched to mark European Myeloma Day | ||
| 26.09. | Sandoz biosimilar receives EC approval to treat MS | ||
| 26.09. | Pfizer's Abrysvo RSV vaccine for infants backed by US CDC | ||
| 26.09. | CDC provides $262.5m to create national network for infectious diseases | ||
| 25.09. | Novo Nordisk Foundation commits €127m for new cell therapy facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
